News

Benefits groups support the proposal, which would require retirement plans to use money forfeited by participants when they leave an employer before the end of a vesting schedule, starting in 2024..

In a lawsuit filed Tuesday, Merck becomes the first major drugmaker to challenge Biden's Inflation Reduction Act, which it says "violates the Constitution" by allowing the government to unilaterally impose its preferred price.

Coherus BioSciences will launch Yusimry – used to treat rheumatoid arthritis and psoriasis – which Cuban's Cost Plus Drugs will be offering starting in July.

The whistleblower, Amy Vermillion, "brought a case [the government] never would have known about, [and the defendants] would have continued the fraud if it wasn't for her bringing this forward," said her lawyer, Mike Bothwell.

A second version of a research paper from last fall shows higher percentage of losses.

Four years after a judge recommended the harshest penalty for drug distributor Morris & Dickson for its "cavalier disregard" of rules aimed at preventing opioid abuses, the Drug Enforcement Administration revoked its license.